A Study for the Mechanism of Abnormal Proliferation in Vascular Endothelial Cells using Inhibitors to the Signal Transduction Pathway
![]() |
Bae, Yong Chan
(Department of Plastic and Reconstructive Surgery, Pusan National University)
Park, Suk Young (Department of Plastic and Reconstructive Surgery, Pusan National University) Nam, Su Bong (Department of Plastic and Reconstructive Surgery, Pusan National University) Herh, Jae Young (Department of Plastic and Reconstructive Surgery, Pusan National University) Kang, Young Seok (Department of Plastic and Reconstructive Surgery, Pusan National University) |
1 | Folkman J: Oinical applications of research on angiogenesis. N Engl J Med 333: 1757, 1995 DOI ScienceOn |
2 | Farivar RS, Thorpe JG, Ito H, Arshad H, Zinner MJ, Ashley SW, Whang EE: The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines. J Surg Res 115: 219, 2003 DOI ScienceOn |
3 | Grabam MA, Rawe I, Dartt DA, Joyce NC: Protein kinase C regulation of corneal endothelial cell proliferation and cell cycle. Invest Ophthalmol Vis Sci 41: 4124, 2000 |
4 | Lee OH, Kim YM, Lee YM, Moon EJ, Lee DJ, Kim JH, Kim KW, Kwon YG: Sphingosine1-phosphat induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem Biophys Res Commun 264: 743, 1999 DOI ScienceOn |
5 | Kim HO, Kang YS, Bae YC Park SY, Hwang SM, Nam SB: Gene expression profiling of 1,2-Dimethylhydrazinestimulated human umbilical vein endothelial cells. J Korean Soc Plast Reconstr Surg 31: 858, 2004 |
6 | Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y:Matrix metalloproteinases cleave connective tissue growth factor and reactiveate angiogenic activity of vascular endothelial growth factor 165. J Bioi Chem 277: 36288, 2002 DOI |
7 | Veikkola T, Alitalo K: VEGFs, receptors and angiogenesis. Seminars in Cancer Bioi 9: 211, 1999 |
8 | Bischoff J: Perspectives series; Cell adhesion in vascular biology. J Clin Invest 99: 373, 1997 DOI ScienceOn |
9 | Brigstock DR: Regulation of angiogenesis and endothelial cell function by connective tissue growth factor(CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 5: 153, 2002 DOI ScienceOn |
10 | Lutz MP, Silke Eer IE, Flossmann-Kast BBM, Vogelmann R, Luhrs H, Friess H, Buchler MW, Adler G: Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun 243: 503, 1998 DOI ScienceOn |
11 | Levitzki A: Protein tyrosine kinase inhibitors as novel therapeutic agents. Pharmacal Ther 82: 231, 1999 DOI ScienceOn |
12 | Chabannes E, Fauconnet S, Bernardini S, Wallerand H, Adessi GL, Bittard H: Protein kinase C signalling pathway is involved in the regulation of vascular endothelial growth factor expression in human bladder transitional carcinoma cells. Cell Signal 13: 585, 2001 |
13 | Amaar YG, Thompson GR, Linkhart TA, Chen ST, Baylink DJ, Mohan S: Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHU). J Bioi Chem 277: 12053, 2002 DOI |
![]() |